PetMed Express Inc (PETS) - Net Assets

Latest as of December 2025: $32.77 Million USD

Based on the latest financial reports, PetMed Express Inc (PETS) has net assets worth $32.77 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($87.97 Million) and total liabilities ($55.20 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore PETS cash generation efficiency to assess how effectively this company generates cash.

Key Net Assets Metrics

Metric Value
Current Net Assets $32.77 Million
% of Total Assets 37.25%
Annual Growth Rate 16.43%
5-Year Change -39.74%
10-Year Change 2.33%
Growth Volatility 62.2

PetMed Express Inc - Net Assets Trend (2000–2026)

This chart illustrates how PetMed Express Inc's net assets have evolved over time, based on quarterly financial data. Explore investment intensity of PetMed Express Inc to see how much of total assets are deployed in long-term investments.

Annual Net Assets for PetMed Express Inc (2000–2026)

The table below shows the annual net assets of PetMed Express Inc from 2000 to 2026. For live valuation and market cap data, see PETS market cap.

Year Net Assets Change
2026-03-31 $85.13 Million -11.99%
2024-03-31 $96.73 Million -12.04%
2023-03-31 $109.97 Million -22.66%
2022-03-31 $142.19 Million +0.64%
2021-03-31 $141.28 Million +8.67%
2020-03-31 $130.01 Million -3.47%
2019-03-31 $134.68 Million +16.37%
2018-03-31 $115.73 Million +23.95%
2017-03-31 $93.37 Million +12.23%
2016-03-31 $83.19 Million +10.29%
2015-03-31 $75.44 Million +7.43%
2014-03-31 $70.22 Million +9.69%
2013-03-31 $64.01 Million -21.15%
2012-03-31 $81.18 Million -16.31%
2011-03-31 $97.00 Million +0.15%
2010-03-31 $96.86 Million +29.20%
2009-03-31 $74.97 Million +11.84%
2008-03-31 $67.03 Million +24.45%
2007-03-31 $53.86 Million +43.10%
2006-03-31 $37.64 Million +55.43%
2005-03-31 $24.22 Million +73.05%
2004-03-31 $13.99 Million +150.23%
2003-03-31 $5.59 Million +253.36%
2002-03-31 $1.58 Million +109.00%
2001-03-31 $757.29K -53.56%
2000-03-31 $1.63 Million --

Equity Component Analysis

This analysis shows how different components contribute to PetMed Express Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 6951414900.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2026)

Component Amount Percentage
Retained Earnings $66.54 Million 78.16%
Common Stock $21.00K 0.02%
Other Components $18.57 Million 21.81%
Total Equity $85.13 Million 100.00%

PetMed Express Inc Competitors by Market Cap

The table below lists competitors of PetMed Express Inc ranked by their market capitalization.

Company Market Cap
Kyung Chang Industrial Co. Ltd
KQ:024910
$46.66 Million
Yellow Balloon Tour Co. Ltd
KQ:104620
$46.71 Million
Kinetiko Energy Ltd
AU:KKO
$46.74 Million
Do Day Dream Public Company Limited
BK:DDD
$46.74 Million
Hwashin Precision Engineering Co. Ltd
KQ:126640
$46.63 Million
Lion One Metals Limited
V:LIO
$46.63 Million
Perdana Bangun Pusaka Tbk PT
JK:KONI
$46.62 Million
Korea Computer Inc
KQ:054040
$46.60 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in PetMed Express Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2026, total equity changed from 96,731,000 to 85,134,000, a change of -11,597,000 (-12.0%).
  • Net loss of 6,271,000 reduced equity.
  • Dividend payments of 181,000 reduced retained earnings.
  • Other factors decreased equity by 5,145,000.

Equity Change Factors (2024 to 2026)

Factor Impact Contribution
Net Income $-6.27 Million -7.37%
Dividends Paid $181.00K -0.21%
Other Changes $-5.14 Million -6.04%
Total Change $- -11.99%

Book Value vs Market Value Analysis

This analysis compares PetMed Express Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.53x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 8.51x to 0.53x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2000-03-31 $0.26 $2.18 x
2001-03-31 $0.08 $2.18 x
2002-03-31 $0.08 $2.18 x
2003-03-31 $0.27 $2.18 x
2004-03-31 $0.59 $2.18 x
2005-03-31 $1.02 $2.18 x
2006-03-31 $1.55 $2.18 x
2007-03-31 $2.22 $2.18 x
2008-03-31 $2.76 $2.18 x
2009-03-31 $3.19 $2.18 x
2010-03-31 $4.26 $2.18 x
2011-03-31 $4.28 $2.18 x
2012-03-31 $3.92 $2.18 x
2013-03-31 $3.19 $2.18 x
2014-03-31 $3.50 $2.18 x
2015-03-31 $3.75 $2.18 x
2016-03-31 $4.11 $2.18 x
2017-03-31 $4.58 $2.18 x
2018-03-31 $5.66 $2.18 x
2019-03-31 $6.57 $2.18 x
2020-03-31 $6.48 $2.18 x
2021-03-31 $7.02 $2.18 x
2022-03-31 $6.98 $2.18 x
2023-03-31 $5.41 $2.18 x
2024-03-31 $4.74 $2.18 x
2026-03-31 $4.13 $2.18 x

Capital Efficiency Dashboard

This dashboard shows how efficiently PetMed Express Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -7.37%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -2.76%
  • • Asset Turnover: 1.53x
  • • Equity Multiplier: 1.75x
  • Recent ROE (-7.37%) is below the historical average (4.51%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2000 -110.02% -12.22% 2.32x 3.88x $-1.96 Million
2001 -373.27% -28.25% 2.22x 5.95x $-2.90 Million
2002 52.15% 2.58% 6.88x 2.94x $667.14K
2003 58.25% 5.93% 6.09x 1.61x $2.70 Million
2004 41.54% 6.19% 5.09x 1.32x $4.41 Million
2005 33.08% 7.39% 3.85x 1.16x $5.59 Million
2006 32.05% 8.77% 3.23x 1.13x $8.30 Million
2007 26.81% 8.90% 2.65x 1.14x $9.06 Million
2008 29.87% 10.63% 2.56x 1.10x $13.32 Million
2009 30.65% 10.47% 2.68x 1.09x $15.48 Million
2010 26.85% 10.91% 2.29x 1.08x $16.32 Million
2011 21.52% 9.01% 2.18x 1.10x $11.17 Million
2012 20.52% 6.99% 2.62x 1.12x $8.54 Million
2013 26.81% 7.53% 3.11x 1.14x $10.76 Million
2014 25.59% 7.70% 2.98x 1.12x $10.95 Million
2015 23.14% 7.61% 2.77x 1.10x $9.91 Million
2016 24.72% 8.76% 2.60x 1.09x $12.25 Million
2017 25.51% 9.56% 2.21x 1.21x $14.48 Million
2018 32.22% 13.62% 2.03x 1.17x $25.71 Million
2019 28.02% 13.32% 1.84x 1.15x $24.27 Million
2020 19.88% 9.10% 1.83x 1.19x $12.85 Million
2021 16.93% 7.88% 1.62x 1.33x $9.79 Million
2022 14.84% 7.72% 1.55x 1.24x $6.88 Million
2023 4.67% 2.00% 1.51x 1.55x $-5.86 Million
2024 -7.72% -2.72% 1.61x 1.76x $-17.14 Million
2026 -7.37% -2.76% 1.53x 1.75x $-14.78 Million

Industry Comparison

This section compares PetMed Express Inc's net assets metrics with peer companies in the Pharmaceutical Retailers industry.

Industry Context

  • Industry: Pharmaceutical Retailers
  • Average net assets among peers: $3,465,474,035
  • Average return on equity (ROE) among peers: 18.47%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
PetMed Express Inc (PETS) $32.77 Million -110.02% 1.68x $46.65 Million
Bimi International Medical Inc (BIMI) $29.81 Million 0.30% 0.44x $1.40K
High Tide Inc (HITI) $-9.66 Million 0.00% 0.00x $210.08 Million
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) $585.24K 170.56% 4.82x $5.96 Million
POMDOCTOR LIMITED American Depositary Shares (POM) $703.00 Million 7.54% 3.09x $12.36 Million
Ridgetech, Inc. (RDGT) $14.29 Million -29.62% 5.65x $1.28 Million
Scienture Holdings, Inc. (SCNX) $844.67K 1.07% 1.64x $15.89 Million
SunLink Health Systems Inc (SSY) $42.39 Million 2.15% 1.53x $7.85 Million
Walgreens Boots Alliance Inc (WBA) $30.41 Billion 14.26% 1.96x $10.37 Billion
Wellgistics Health, Inc. Common Stock (WGRX) $-5.25K 0.00% 0.00x $26.39 Million

About PetMed Express Inc

NASDAQ:PETS USA Pharmaceutical Retailers
Market Cap
$46.65 Million
Market Cap Rank
#22270 Global
#4798 in USA
Share Price
$2.18
Change (1 day)
-2.24%
52-Week Range
$1.60 - $4.19
All Time High
$44.49
About

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional suppleme… Read more